FAIR VALUE MEASUREMENTS (Details Narrative) - $ / shares |
Dec. 31, 2023 |
Jul. 06, 2023 |
Dec. 31, 2022 |
Nov. 03, 2022 |
Dec. 21, 2021 |
Dec. 17, 2021 |
|---|---|---|---|---|---|---|
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Warrants purchase, shares | 7,609,879 | 1,788,000 | 1,788,000 | |||
| Warrants exercise price | $ 4.0299 | $ 4.75 | $ 9.75 | $ 9.75 | ||
| Private Placement [Member] | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Warrants purchase, shares | 7,609,879 | 7,609,879 | ||||
| Warrants exercise price | $ 4.75 | $ 4.75 | ||||
| 2021 Public Offering [Member] | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Warrants purchase, shares | 1,788,000 | 1,788,000 | ||||
| Warrants exercise price | $ 9.75 | $ 9.75 |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|